Jody A. Charnow

Editor

Jody A. Charnow has been the editor of Renal & Urology News, a publication of Haymarket Media, since 2003. Previously, he had served as editor of Internal Medicine World Report and a managing editor for Medical Tribune. He holds a BA in biology from the State University of New York at Albany.

All articles by Jody A. Charnow

Systemic Lupus Erythematosus

Kidney Failure Predictor in Lupus Nephritis Identified

Jody A. Charnow

September 28, 2022

Persistent isolated C3 hypocomplementemia is associated with an increased risk for end-stage kidney disease or death in patients with proliferative lupus nephritis, a study revealed.

General Medicine

Study: RenalGuard Not Superior in Avoiding Contrast-Induced Nephropathy

Jody A. Charnow

August 19, 2022

Latest findings from a study of RenalGuard contrast with those of previous randomized controlled trials.

Gout

Gout Common in Advanced Kidney Disease and Dialysis

Jody A. Charnow

April 18, 2022

Nearly 24% of patients with advanced CKD, including those on dialysis, have gout, according to a study.

Gout

Gout Common in the US Dialysis Population

Jody A. Charnow

November 23, 2021

New analysis suggests that gout prevalence is 21% among patients on peritoneal dialysis and 13% among those on hemodialysis.

Gout

Urate-Lowering Therapy Not Renoprotective When Kidney Function is Normal

Jody A. Charnow

November 19, 2021

New findings complement previous research showing no renoprotective effect of urate-lowering therapy in patients with chronic kidney disease.

General Medicine

Sodium Abnormalities at Hospital Admission More Likely With COVID-19

Jody A. Charnow

November 17, 2021

Hyponatremia and hypernatremia in patients hospitalized for COVID-19 are associated with increased odds of adverse outcomes.

Gout

Gout Prevalence Is Increasing Among US Veterans

Jody A. Charnow

October 4, 2021

Gout prevalence in Veterans Affairs medical centers increased from 4.2% in 2005 to 5.8% in 2014.

Hands Of Woman Deformed From Rheumatoid Arthritis holding pills

Gout

Urate-Lowering Therapy Associated With Decreased Gout Flare Risk

Jody A. Charnow

August 18, 2021

Patients with asymptomatic hyperuricemia who achieved serum uric acid levels of 6.0 mg/dL or less while on urate-lowering therapy had fewer gout flare episodes, a study found.

Gout

Hyperuricemia Increases Risks for Cardiovascular and All-Cause Mortality

Jody A. Charnow

August 6, 2021

Each 1 mg/dL rise in uric acid level was significantly associated with a 21% and 10% increased risk for cardiovascular and all-cause mortality, respectively, a study found.

Gout

Hyperuricemia and Gout Do Not Raise Dementia Risk

Jody A. Charnow

July 30, 2021

Hyperuricemia and gout may be associated with a lower risk for Alzheimer disease.

Next post in Gout